Novel 3-D cell culture system for in vitro evaluation of anticancer drugs under anchorage-independent conditions

Cancer Science

Volumn 107, Issue 12, 2016, Pages 1858-1866

  Aihara, Ayako ^a   Abe, Natsuki ^a   Saruhashi, Koichiro ^a   Kanaki, Tatsuro ^a   Nishino, Taito ^a  

^a NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

3 D cell culture; anticancer drugs; gellan gum; high throughput screening (HTS); spheroids

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; ERLOTINIB; FIBROBLAST GROWTH FACTOR 2; GEFITINIB; GELLAN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOMYCIN; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN C; TRAMETINIB; TRANSFORMING GROWTH FACTOR BETA; EPIDERMAL GROWTH FACTOR RECEPTOR;

A-549 CELL LINE; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BLOOD VISCOSITY; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HEP-G2 CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHEROID CELL; APOPTOSIS; CELL CULTURE TECHNIQUE; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; MULTICELLULAR SPHEROID; PROCEDURES; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; EPIDERMAL GROWTH FACTOR; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 85006963835     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.13095     Document Type: Article

References (28)

1. Arrondeau J, Gan HK, Razak AR, Paoletti X, Le Tourneau C. Development of anti-cancer drugs. Discov Med 2010; 10: 355–62.
2. Hait WN. Anticancer drug development; the grand challenges. Nat Rev Drug Discov 2010; 9: 253–4.
3. Hopkins AL. Network pharmacology; the next paradigm in drug discovery. Nat Chem Biol 2008; 4: 682–90.
4. Kola I. The state of innovation in drug development. Clin Pharmacol Ther 2008; 83: 227–30.
5. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004; 9: 273–85.
6. Gregory EH, Chungyee L, Lindafitz F et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature 1996; 379: 91–6.
7. Freedman VH, Shin SI. Cellular tumorigenicity in nude mice correlation with cell growth in semi-solid medium. Cell 1974; 3: 355–9.
8. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9: 701–6.
9. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001; 189: 1–13.
10. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003; 15: 753–62.
11. Breslin S, O'Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 2013; 18: 240–9.
12. Longati P, Jia X, Eimer J et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 2013; 13: 95.
13. Smalley KS, Lioni M, Noma K, Haass NK, Herlyn M. In vitro three-dimensional tumor microenvironment models for anticancer drug discovery. Expert Opin Drug Discov 2008; 3: 1–10.
14. Otsuji TG, Bin J, Yoshimura A et al. A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production. Stem Cell Rep 2014; 2: 734–45.
15. Wang H, Wu R, Yu L et al. SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression. Oncol Rep 2012; 28: 1468–74.
16. Nitta Y, Nishinari K. Gelation and gel properties of polysaccharides gellan gum and tamarind xyloglucan. J Biol Macromol 2005; 5: 47–52.
17. Pérez-Camposa SJ, Chavarría-Hernándeza N, Tecanteb A, Ramírez-Gillyb M, Rodríguez-Hernández AI. Gelation and microstructure of dilute gellan solutions with calcium ions. Food Hydrocoll 2012; 28: 291–300.
18. Amundadottir LT, Leder P. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 1998; 16: 737–46.
19. Moore SM, Rintoul RC, Walker TR et al. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 1998; 68: 5239–47.
20. Shibnath G, Suniti M, Bryan PT. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002; 277: 38013–20.
21. Parse IV, Lee J, Juliane RL. New aspects of integrin signaling in cancer. Semin Cancer Biol 2000; 10: 407–14.
22. Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999; 274: 16349–54.
23. Yang T, Barbone D, Fennell DA, Broaddus VC. Bcl-2 Family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Am J Respir Cell Mol Biol 2009; 41: 14–23.
24. Hirai H, Sootome H, Nakatsuro Y et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 2010; 7: 1956–67.
25. Tanaka Y, Miyamoto S, Suzuki SO et al. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res 2005; 11: 4783–92.
26. Ongusaha PP, Kwak JC, Zwible AJ et al. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 2004; 64: 5283–90.
27. Wang H, Li S, Li H et al. SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes. Carcinogenesis 2013; 34: 1976–83.
28. Howes AL, Richardson RD, Finlay D, Vuori K. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems. PLoS ONE 2014; 9: e108283.